Score Overview
Explore the 2021 public Archive ranking โ
Where Innoviva Inc has ranked, year by year
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 30 years of fundamentals. INVA does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 21.23 | โ |
1 Year2025-09-26 | $ 18.86 | 12.57% |
5 Years2021-09-28 | $ 17.20 | 23.43% |
10 Years2016-09-28 | $ 11.21 | 89.38% |
20 Years2006-09-28 | $ 20.00 | 6.13% |
All Time2004-10-05 | $ 13.55 | 56.71% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | All Time2004-10-05 |
|---|---|---|---|---|---|---|
| Price | $ 21.23 | $ 18.86 | $ 17.20 | $ 11.21 | $ 20.00 | $ 13.55 |
| Return | โ | 12.57% | 23.43% | 89.38% | 6.13% | 56.71% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 443M | $ 357M | $ 570M |
| 2025 | $ 425M | $ 271M | $ 550M |
| 2024 | $ 358M | $ 23M | $ 412M |
| 2023 | $ 310M | $ 179M | $ 193M |
| 2022 | $ 331M | $ 213M | $ 291M |
| 2021 | $ 391M | $ 265M | $ 201M |
| 2020 | $ 336M | $ 224M | $ 246M |
| 2019 | $ 261M | $ 157M | $ 350M |
| 2018 | $ 261M | $ 395M | $ 114M |
| 2017 | $ 217M | $ 134M | $ 129M |
| 2016 | $ 133M | $ 59M | $ 150M |
| 2015 | $ 53M | -$ 18M | $ 187M |
| 2014 | $ 8M | -$ 168M | $ 240M |
| 2013 | $ 4M | -$ 170M | $ 465M |
| 2012 | $ 5M | -$ 18M | $ 248M |
| 2011 | $ 24M | -$ 115M | $ 240M |
| 2010 | $ 24M | -$ 83M | $ 309M |
| 2009 | $ 24M | -$ 85M | $ 155M |
| 2008 | $ 23M | -$ 93M | $ 200M |
| 2007 | $ 22M | -$ 159M | $ 126M |
| 2006 | $ 19M | -$ 166M | $ 201M |
| 2005 | $ 12M | -$ 143M | $ 161M |
| IPO2004 | $ 8M | -$ 102M | $ 257M |

Innoviva Inc fundamental performance
Between 2015 and 2025, revenue grew from $ 53M to $ 425M and net income went from -$ 18M to $ 271M. Revenue increased in 8 of those 10 years; net income in 6.
Between 2005 and 2025, revenue grew from $ 12M to $ 425M and net income went from -$ 143M to $ 271M. Revenue increased in 15 of those 20 years; net income in 14.
Innoviva Inc currently holds a 20-year HDB Score of 5.5 out of 10. How the HDB Score is calculated.
Membership
Explore INVA with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
Neogen CorporationNEOGยท revenue grew in 90% of years
Omnicell IncOMCLยท revenue grew in 80% of years
Fresenius Medical Care CorporationFMSยท revenue grew in 80% of years
Ligand Pharmaceuticals IncorporatedLGNDยท revenue grew in 75% of years
Bristol-Myers Squibb CompanyBMYยท revenue grew in 65% of years